
Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme
Confusion over new Medicare negotiating plans sent Regeneron Pharmaceuticals (REGN) and Halozyme Therapeutics (HALO) stocks tumbling Thursday. REGN stock undercut its 50-day line and HALO stock hit a year-low. Under a new program launching in […]